Skip to content

AI on the agenda at Bio-Partnering conference


Person stands next to giant projector screen while giving a presentation at a conference

Delegates learned more about Artificial Intelligence (AI) in healthcare as part of a ‘Bio-Partnering’ conference supported by the University of Bradford.

The third annual Yorkshire Bio-Partnering event, co-hosted by the university’s Institute of Cancer Therapeutics, featured keynote speeches and selected case studies which showed more than 80 delegates where to find collaborative research funding and support available both in the region and nationally.

This year’s event, in collaboration with partners Bionow, featured keynote lectures from Helen Oldham, co-founder of Lifted Ventures, a firm which aims to promote the business benefits of supporting women. She is also a board member of the UK Business Angels Association (UKBAA) and a member of the Women Angel Investment Taskforce. 

Person stood at a conference podium gives speech during event

Professor Helen Philippou, pictured above, Professor of Translational Medicine at the University of Leeds, was the event’s second keynote speaker. She co-founded ClotProtect Therapeutics Limited, which looks to meet the clinical needs of patients bleeding in major surgery and trauma.

Dr Jason Jones, pictured below, Commercial Manager at the Faculty of Life Sciences at the University of Bradford, said: “The Yorkshire Bio-Partnering is now established as an important regional event that brings together academia and industry to highlight the support and funding that is available both regionally and nationally for collaborative translational research. It provides the opportunity for delegates to ignite new relationships.”

University staff member stood behind podium next to giant screen giving presentation at a conference

The event, held at Bradford’s Cedar Court Hotel, featured discussions on subjects including AI in healthcare and sustainability in bioscience. 

These sessions saw presentations from regional and national companies including PinPoint Data Science, Carmen Diagnostic Technologies, Phyla Earth and Origin Pharma. The strengths of the University of Bradford in these research fields were highlighted.

Professor Sherif El-Khamisy, pictured below, Director of the Institute of Cancer Therapeutics at the University of Bradford, said: “It was great to see the success of the third edition of the Yorkshire Bio-partnering conference hosted by ICT and Bionow. This year saw delegates including representatives from Yorkshire HES, government and SMEs.”

A person holding a mobile phone stands talking on a stage at a conference

The conference looked at collaborative research funding and support in the region and nationally, with presentations from the Northern Powerhouse, IUK Business Growth, ICURe, the University of Bradford and the Investor Ladder. 

Dr Geoff Davison, Bionow’s CEO, said: “It was great to see the spirit of collaboration alive and well at the event with an agenda of speakers, discussions, exhibitors, partnering meetings and networking.

“Industry, clinicians and academia all came together to promote successful partnerships and funding opportunities within the sector, and I am confident that we will see exciting new innovations as a result.”